1,534
Views
15
CrossRef citations to date
0
Altmetric
Review

Comparing the immunogenicity and safety of 3 Japanese encephalitis vaccines in Asia-Pacific area: A systematic review and meta-analysis

, , , , &
Pages 1418-1425 | Received 06 Oct 2014, Accepted 30 Dec 2014, Published online: 18 Jun 2015

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (3)

Ya-Li Hu & Ping-Ing Lee. (2021) Safety of Japanese encephalitis vaccines. Human Vaccines & Immunotherapeutics 17:11, pages 4259-4264.
Read now
Amy Sarah Ginsburg, Ankita Meghani, Scott B. Halstead & Mansour Yaich. (2017) Use of the live attenuated Japanese Encephalitis vaccine SA 14–14–2 in children: A review of safety and tolerability studies. Human Vaccines & Immunotherapeutics 13:10, pages 2222-2231.
Read now
Nagendra R. Hegde & Milind M. Gore. (2017) Japanese encephalitis vaccines: Immunogenicity, protective efficacy, effectiveness, and impact on the burden of disease. Human Vaccines & Immunotherapeutics 13:6, pages 1320-1337.
Read now

Articles from other publishers (12)

Andrea De Vito, Agnese Colpani, Mattia Trunfio, Vito Fiore, Giulia Moi, Marco Fois, Nicola Leoni, Stefano Ruiu, Sergio Babudieri, Andrea Calcagno & Giordano Madeddu. (2023) Living with HIV and Getting Vaccinated: A Narrative Review. Vaccines 11:5, pages 896.
Crossref
Xuelian Han, Zhuming Cai, Yulong Dai, He Huang, Xiangwen Cao, Yuan Wang, Yingying Fang, Gang Liu, Min Zhang, Yuhang Zhang, Binhui Yang, Wei Xue, Guangyu Zhao, Wanbo Tai & Min Li. (2022) Re-burying Artificially Exposed Surface of Viral Subunit Vaccines Through Oligomerization Enhances Vaccine Efficacy. Frontiers in Cellular and Infection Microbiology 12.
Crossref
Nazmul Islam, Chang Xu, Colleen L. Lau, Deborah J. Mills, Justin Clark, Gregor J. Devine, Leon E. Hugo, Narayan Gyawali, Lukman Thalib & Luis Furuya-Kanamori. (2022) Persistence of antibodies, boostability, and interchangeability of Japanese encephalitis vaccines: A systematic review and dose-response meta-analysis. Vaccine 40:26, pages 3546-3555.
Crossref
Luis Furuya-Kanamori, Chang Xu, Suhail A.R. Doi, Justin Clark, Kinley Wangdi, Deborah J. Mills & Colleen L. Lau. (2021) Comparison of immunogenicity and safety of licensed Japanese encephalitis vaccines: A systematic review and network meta-analysis. Vaccine 39:32, pages 4429-4436.
Crossref
Vijaya Satchidanandam. (2020) Japanese Encephalitis Vaccines. Current Treatment Options in Infectious Diseases 12:4, pages 375-386.
Crossref
Yixuan XuQiao WangBowen WeiXiaobo HuangYiping WenQigui YanXiaoping MaQin ZhaoSanjie CaoYong HuangXintian WenXinfeng HanYu BaiRui Wu. (2019) Enhanced Immune Responses Against Japanese Encephalitis Virus Infection Using Japanese Encephalitis Live-Attenuated Virus Adjuvanted with Montanide GEL 01 ST in Mice. Vector-Borne and Zoonotic Diseases 19:11, pages 835-843.
Crossref
Anju Aggarwal & Neha Garg. (2017) Newer Vaccines against Mosquito-borne Diseases. The Indian Journal of Pediatrics 85:2, pages 117-123.
Crossref
Eduardo Alves dos Santos & Katja Fink. 2018. Dengue and Zika: Control and Antiviral Treatment Strategies. Dengue and Zika: Control and Antiviral Treatment Strategies 215 239 .
Quanhathai Kaewpoowat, Linda Aurpibul & Rommanee Chaiwarith. 2018. Meningitis and Encephalitis. Meningitis and Encephalitis 153 174 .
Brian Nickols, Irina Tretyakova, Alexander Tibbens, Elena Klyushnenkova & Peter Pushko. (2017) Plasmid DNA launches live-attenuated Japanese encephalitis virus and elicits virus-neutralizing antibodies in BALB/c mice. Virology 512, pages 66-73.
Crossref
Anna Maria Geretti, Gary Brook, Claire Cameron, David Chadwick, Neil French, Robert Heyderman, Antonia Ho, Michael Hunter, Shamez Ladhani, Mark Lawton, Eithne MacMahon, John McSorley, Anton Pozniak & Alison Rodger. (2016) British HIV Association Guidelines on the Use of Vaccines in HIV-Positive Adults 2015. HIV Medicine 17, pages s2-s81.
Crossref
K.M. Damer & C.M. Jung. 2016. A Worldwide Yearly Survey of New Data in Adverse Drug Reactions. A Worldwide Yearly Survey of New Data in Adverse Drug Reactions 307 334 .

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.